Component

Clostridium sporogenes PorA

Context-specific entity; species, compartment and exposure are stated on each claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Clostridium sporogenes porA disruption reduced the oxidative conversion of phenylalanine-derived carbon to phenylacetate; labeled phenylalanine tracing supported the pathway through phenylpyruvate.

    Experimental context and source evidence
    evidence_access
    Primary full text
    experimental_model
    Defined bacterial cultures and stable-isotope experiments; 100 micromolar labeled phenylalanine over 24 hours.
    limitations
    Bacterial flux is strain- and environment-dependent; no human dietary conversion fraction is established.
    nutrient_topic
    L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
    plain_language
    Some gut bacteria send phenylalanine into a different metabolic route.
    primary_references
    A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32142679/ · DOI 10.1016/j.cell.2020.02.016

    L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 342–348

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Defined bacterial cultures and stable-isotope experiments; 100 micromolar labeled phenylalanine over 24 hours. · source_derived_draft · unverified_draft

    ## l-phenylalanine-microbial-oxidation Some gut bacteria send phenylalanine into a different metabolic route. Clostridium sporogenes porA disruption reduced the oxidative conversion of phenylalanine-derived carbon to phenylacetate; labeled phenylalanine tracing supported the pathway through phenylpyruvate. Model: Defined bacterial cultures and stable-isotope experiments; 100 micromolar labeled phenylalanine over 24 hours. Limitations: Bacterial flux is strain- and environment-dependent; no human dietary conversion fraction is established. Evidence access: Primary full text A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32142679/ · DOI 10.1016/j.cell.2020.02.016
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. The C. sporogenes FldH-dependent reductive aromatic-amino-acid branch competed with the PorA-associated oxidative branch; gene perturbations changed phenylacetate versus phenylpropionate output.

    Experimental context and source evidence
    evidence_access
    Primary full text
    experimental_model
    C. sporogenes mutant culture and metabolite measurements.
    limitations
    A branch in one organism is not a fixed whole-microbiome fate map.
    nutrient_topic
    L-Phenylalanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Phenylalanine
    plain_language
    Which microbial enzymes are present can change which metabolite is produced.
    primary_references
    A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32142679/ · DOI 10.1016/j.cell.2020.02.016

    L-Phenylalanine: transport, protein synthesis, cofactor recycling and cross-nutrient mechanisms (2026-09-19) · lines 350–356

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · C. sporogenes mutant culture and metabolite measurements. · source_derived_draft · unverified_draft

    ## l-phenylalanine-microbial-branch Which microbial enzymes are present can change which metabolite is produced. The C. sporogenes FldH-dependent reductive aromatic-amino-acid branch competed with the PorA-associated oxidative branch; gene perturbations changed phenylacetate versus phenylpropionate output. Model: C. sporogenes mutant culture and metabolite measurements. Limitations: A branch in one organism is not a fixed whole-microbiome fate map. Evidence access: Primary full text A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32142679/ · DOI 10.1016/j.cell.2020.02.016
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards